Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (51-60 of 1,111) with videos related to

Pageof 112
Sort By:
European Heart Journal|June 26, 2012
Towards evidence-based percutaneous coronary intervention: the René Laënnec lecture in clinical cardiologyPatrick A Calvert, P Gabriel Steg
The New England Journal of Medicine|September 12, 2019
Open versus Endovascular Repair of Abdominal Aortic AneurysmQuentin Pellenc, Yves Castier, P Gabriel Steg
Circulation|March 9, 2007
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernEdoardo Camenzind, P Gabriel Steg, William Wijns
JAMA|June 22, 2021
Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-ReplyGregory Ducrocq, Tabassome Simon, P Gabriel Steg, et al.
European Journal of Preventive Cardiology|March 10, 2025
Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: ReplyGregory G Schwartz, Michael Szarek, Philippe Gabriel Steg
European Heart Journal|October 12, 2017
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrumCian P McCarthy, Gabriel Steg, Deepak L Bhatt
JACC. Cardiovascular Interventions|January 25, 2015
Follow the data: bivalirudin (and not heparin alone) during percutaneous coronary intervention provides the best clinical outcomesGregg W Stone, Roxana Mehran, Philippe Gabriel Steg
The New England Journal of Medicine|May 23, 2019
Alirocumab after Acute Coronary Syndrome. ReplyGregory G Schwartz, P Gabriel Steg, Michael Szarek
Circulation|February 24, 2025
New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain EvidenceEmmanuelle Vidal-Petiot, Sofiane Kab, Philippe Gabriel Steg
Kardiologia Polska|July 9, 2014
Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registryJanina Stępińska, Miłosz Marona, Nicola Greenlaw, et al.
Pageof 112

Showing results (51-60 of 1,111) with videos related to

Sort By:
Pageof 112
European Heart Journal|June 26, 2012
Towards evidence-based percutaneous coronary intervention: the René Laënnec lecture in clinical cardiologyPatrick A Calvert, P Gabriel Steg
The New England Journal of Medicine|September 12, 2019
Open versus Endovascular Repair of Abdominal Aortic AneurysmQuentin Pellenc, Yves Castier, P Gabriel Steg
Circulation|March 9, 2007
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernEdoardo Camenzind, P Gabriel Steg, William Wijns
JAMA|June 22, 2021
Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-ReplyGregory Ducrocq, Tabassome Simon, P Gabriel Steg, et al.
European Journal of Preventive Cardiology|March 10, 2025
Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: ReplyGregory G Schwartz, Michael Szarek, Philippe Gabriel Steg
European Heart Journal|October 12, 2017
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrumCian P McCarthy, Gabriel Steg, Deepak L Bhatt
JACC. Cardiovascular Interventions|January 25, 2015
Follow the data: bivalirudin (and not heparin alone) during percutaneous coronary intervention provides the best clinical outcomesGregg W Stone, Roxana Mehran, Philippe Gabriel Steg
The New England Journal of Medicine|May 23, 2019
Alirocumab after Acute Coronary Syndrome. ReplyGregory G Schwartz, P Gabriel Steg, Michael Szarek
Circulation|February 24, 2025
New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain EvidenceEmmanuelle Vidal-Petiot, Sofiane Kab, Philippe Gabriel Steg
Kardiologia Polska|July 9, 2014
Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registryJanina Stępińska, Miłosz Marona, Nicola Greenlaw, et al.
Pageof 112